Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

Greetings PL, all of us are pleased that you have a communication line to the company.
As you inferred, not much meat on the bone.
To gain an AML approval after P11 would be great as this disease is a short term killer. If MRKR gained a 50% penetration, I wonder what the revenue would be.

I also deeply wish updated results on the long testing of the TPIV linicsl.lines of which $ millions have been spent... while asking, why could the company not comment lightly on Polystart?
... I am no different than all other current investors clearly wanting to know more... to have hope... to see success.

Try to talk with them again? Good to hear from you..